Exhausted T cells express multiple co-inhibitory molecules that impair their function and limit immunity to chronic viral infection. Defining novel markers of exhaustion is important both for identifying and potentially reversing T cell exhaustion. Herein, we show that the ectonucleotidse CD39 is a marker of exhausted CD8 + T cells. CD8 + T cells specific for HCV or HIV express high levels of CD39, but those specific for EBV and CMV do not. CD39 expressed by CD8 + T cells in chronic infection is enzymatically active, co-expressed with PD-1, marks cells with a transcriptional signature of T cell exhaustion and correlates with viral load in HIV and HCV. In the mouse model of chronic Lymphocytic Choriomeningitis Virus infection, virus-specific CD8 + T cells contain a population of CD39 high CD8 + T cells that is absent in functional memory cells elicited by acute infection. This CD39 high CD8 + T cell population is enriched for cells with the phenotypic and functional profile of terminal exhaustion. These findings provide a new marker of T cell exhaustion, and implicate the purinergic pathway in the regulation of T cell exhaustion.
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Author Summary
Chronic viral infection induces an acquired state of T cell dysfunction known as exhaustion. Discovering surface markers of exhausted T cells is important for both to identify
Introduction
In acute infections, antigen-specific T cells differentiate into activated effector cells and then into memory T cells which rapidly gain effector functions and re-expand on subsequent encounter with the same pathogen [1] . In contrast, during chronic infections, pathogen-specific T cells gradually lose effector functions, fail to expand, and can eventually become physically deleted [2] . These traits are collectively termed T cell exhaustion, and have been described both in animal models of chronic viral infection as well as in human infections with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) [2] [3] [4] . Identifying reversible mechanisms of T cell exhaustion is therefore a major goal in medicine. Prolonged or high-level expression of multiple inhibitory receptors such as PD-1, Lag3, and CD244 (2B4) is a cardinal feature of exhausted T cells in both animal models and human disease [5] [6] [7] . Expression of PD-1 appears to be a particularly important feature of exhausted CD8 + T cells, as the majority of exhausted cells in mouse models of chronic infection express this receptor, and blockade of the PD-1:PD-L1 axis can restore the function of exhausted CD8 + T cells in humans and mouse models [2, 6] . However, in humans, many inhibitory receptors also can be expressed by a large fraction of fully functional memory CD8 + T cells. PD-1, for instance, can be expressed by up to 60% of memory CD8 + T cells in healthy individuals, making it challenging to use PD-1 to identify exhausted CD8 + T cells in humans, particularly when the antigen-specificity of potentially exhausted CD8 + T cells is not known [8] .
Studies in mice and humans suggest that exhausted CD8 + T cells are not a homogeneous population, but instead include at least two subpopulations of T cells that differentially express the transcription factors T-bet and Eomesodermin (Eomes) [9] [10] [11] . T-bet high CD8 + T cells represent a progenitor subset with proliferative potential that give rise to Eomes high CD8 + T cells, which are terminally differentiated and can no longer proliferate in response to antigen or be rescued by PD-1 blockade [9, 12] . Both populations express PD-1, but Eomes high exhausted cells express the highest levels of PD-1. However, no specific cell-surface markers of this terminally differentiated population of exhausted cells have thus far been identified. CD39 (ENTPD1) is an ectonucleotidase originally identified as an activation marker on human lymphocytes and as the vascular ecto-ADPase [13] , but has subsequently been shown to be a hallmark feature of regulatory T cells [14] [15] [16] . CD39 hydrolyzes extracellular ATP and ADP into adenosine monophosphate, which is then processed into adenosine by CD73, an ecto-5'-nucleotidase [17] . Adenosine is a potent immunoregulator that binds to A2A receptors expressed by lymphocytes causing accumulation of intracellular cAMP, preventing T cell activation and NK cytotoxicity [18] [19] [20] . Loss of CD39 in Tregs markedly impairs their ability to suppress T cell activation, suggesting that the juxtacrine activity of CD39 serves to negatively regulate T cell function [15] . However, blood CD8 + T cells have generally been reported to be
CD39
- [14, [21] [22] [23] , and the expression of this marker on exhausted T cells has not been examined. 
Results

CD39 is expressed by CD8 + T cells responding to chronic infection
We surveyed the expression of CD39 by CD8 + T cells from healthy adult subjects without chronic viral infection. Consistent with previous reports we found that only a small fraction (mean 6%) of CD8 + T cells in healthy individuals expressed CD39 (Fig 1A and 1B) [14, [21] [22] [23] .
This small population of CD39 + CD8 + T cells in healthy donors was primarily found in the central and effector memory compartments while virtually no naive CD8 + T cells expressed
We next focused on CD39 expression by antigen-specific CD8 + T cells specific for latent viruses in healthy subjects and found that only a very small fraction of CMV-or EBV-specific CD8 + T cells expressed CD39 (Fig 1A and 1B) (mean 3% and 7% respectively).
We next measured CD39 expression by T cells specific for the chronic viral pathogens HCV and HIV. We measured CD39 expression in 57 subjects with acute HCV infections (23 with acute resolving infection and 34 with chronically evolving infection), and in 40 subjects with HIV infection (28 chronic progressors and 12 controllers; clinical characteristics of the subjects are summarized in S1 Table) . We found a mean of 51% of HCV-specific CD8 + T cells and 31%
of HIV-specific CD8 + T cells expressed CD39, a number significantly higher than CD8 + T cells specific for EBV or CMV, or in total CD8 + T cell populations from healthy individuals (Fig 1A   and 1B) . A slightly greater fraction of virus-specific CD8 + T cells from HCV-infected subjects expressed CD39 than did those from HIV-infected subjects.
In subjects with chronic infection, the frequency of CD39-expressing cells in the virus-specific (tetramer + ) CD8 + T cell population was significantly higher than in the total CD8 + T cell population (Fig 1C and 1D ). However the fraction of total CD8 + T cells expressing CD39 in the CD8 + T cell compartment of individuals with HCV or HIV infection was slightly increased compared to healthy controls (Fig 1E) , consistent with the presence of other, unmeasured virus-specific CD8 + T cells that were also CD39 + in the tetramer − fraction of CD8 + T cells.
Thus CD39 is expressed infrequently by CD8 + T cells in healthy donors, but marks a large fraction of pathogen-specific cells CD8 + T cells in patients with chronic infection.
CD39 expressed by CD8 + T cells hydrolyzes ATP
CD39 expressed by regulatory T cells catalyzes the hydrolysis of ADP to 5'-AMP [14] [15] [16] but its enzymatic activity can be regulated by a range of post-transcriptional mechanisms [PMID.
We therefore tested CD39 expressed by CD8 + T cells from patients infected with chronic HCV was functional using ATP hydrolysis as a surrogate marker of CD39 activity [24] [25] [26] . We sorted CD39 -and CD39 + CD8 + T cells from six HCV-infected individuals (four with chronic infection and two with resolved infection) and incubated equal numbers of cells in the presence of extracellular ATP (eATP). Remaining levels of eATP were measured in the supernatant by HPLC. As a control, we assessed ATP hydrolysis by CD4 + CD25 + CD39 + regulatory T cells (Tregs) sorted from the same individuals (Fig 2A) .
Within the CD39 + CD8 + T cell population the level of CD39 expression was lower than in Tregs (Fig 2B) . Consistent with reduced CD39 expression relative to Tregs, ATP hydrolysis by CD39 + CD8 + T cells was less than that by Tregs (Fig 2C) . However ATP hydrolysis by CD39 + CD8 + T cells was significantly greater than that of CD39 -cells (Fig 2C) . Thus CD39 expressed by CD8 + T cells in HCV infection is enzymatically active and capable of hydrolyzing ATP. patients infected with HIV (28 chronic progressors, 7 viremic controllers and 5 elite controllers). In both diseases we found a significant association between the level of expression (mean fluorescence intensity, MFI) of CD39 and PD-1 on antigen-specific CD8 + T cells in subjects with HCV and with HIV (r = 0.70, P <0.0001 and r = 0.54, P<0.05, respectively) ( Fig 3A and  3B) . We next examined the relationship between CD39 and PD-1 expression and viral load in HCV and HIV infection. We found that in both the HCV and HIV infection there was a modest but significant correlation between viral load and the level of CD39 expression on virus-specific CD8 + T cells measured by MFI (Fig 3C) . Table) . We first used unbiased clustering approaches to identify whether CD39 + and CD39 -CD8 + T cells showed distinct patterns of gene expression. Analysis of gene expression profiles using consensus hierarchical clustering ( Fig 4A) showed two distinct clusters of samples that Table) . Inspection of the list of differentially expressed genes revealed many with known roles in CD8 + T cell biology including increased expression of the inhibitory receptors PD-1 and CTLA-4 in CD39 + CD8 + T cells.
To identify biological processes that were differentially active in CD39 + vs. CD39 -cells, we performed gene set enrichment analysis using the Gene Ontology collection of gene sets [28] . We found no significant enrichment of GO terms in the CD39 -CD8 + subset. In contrast, 21
gene sets significantly enriched (FDR<0.1) in CD39 + population, almost all of which were related to mitosis and cell-cycle associated genes or cytoskeleton organization ( Fig 4B) (Fig 4C) . We focused on the "leading edge" genes contributing most to the enrichment [32] , which correspond to genes up-regulated both in the mouse exhausted signature and in the human CD39 + profile. As expected, the leading edge genes included PD-1 (PDCD1), a feature of both human CD39 + CD8 + T cells and of exhausted CD8 + T cells in the mouse model (Fig 4D) . In addition we found that up-regulation of many genes associated with proliferation including BUB1, TOP2A and MKI67 was common to mouse exhausted CD8 + T cells and human CD39 + CD8 + T cells. Thus CD39 + CD8 + T cells in HCV infection and exhausted CD8 + T cells in a mouse model of chronic infection share transcriptional features that include genes related to proliferation.
CD39 is increased in exhausted CD8 + T cells in the mouse model of chronic LCMV infection
Because the mouse signature of CD8 + T cell exhaustion was significantly enriched in the transcriptional profile of CD39 + CD8 + T cells in HCV-infected patients, we next asked if CD39 was up-regulated by CD8 + T cells in the mouse model of chronic viral infection. To address this question we compared two well-described mouse models of viral infection using two strains of LCMV: LCMV Armstrong that causes an acute infection that is resolved in up to 8 days; and LCMV Clone 13 that persists in mice for up to 3 months and leads to T cell exhaustion [5, 6] . We measured CD39 expression and compared it to PD-1 expression in CD8 + T cells responding to each infection. While naive CD8 + T cells expressed neither CD39 nor PD-1 ( 
CD39 correlates with reduced functionality in virus-specific CD8 + T cells in chronic infection
We next examined the functional properties of CD39 high and CD39 int CD8 + T cells from mice with chronic LCMV infection. Co-production of cytokines IFN-γ and TNFα is a feature of virus-specific T cells responding to acute infection and in the early stages of chronic infection but is progressively lost as exhaustion evolves [2] . (Fig 7C and 7D) . The defect in cytokine secretion was not only observed in terms of the frequency of cytokine-secreting cells, but also in the amount of cytokine detected per cell. Even among cells that did secrete IFN-γ, we found the MFI of expression to be significantly lower in CD39 high CD8 + T cells compared to CD39 int CD8 + T cells (Fig 7E and 7F) . Thus high levels of CD39 expression demarcate a population of exhausted cells with the poorest function in chronic infection. 
Discussion
The state of CD8 + T cell exhaustion is characterized by widespread changes in gene expression relative to functional memory CD8 + T cells [5] . However, in humans, identification of specific T cell exhaustion markers that are not shared by more functional CD8 + T cell populations has been challenging [8] . We show that high-level expression of the ectonucleotidase CD39 is characteristic of CD8 + T cells specific for chronic viral infections in humans and mice, but is otherwise rare in the CD8 + T cell compartment of healthy donors. Persistent, high-level expression is also seen in the LCMV mouse model of chronic viral infection, suggesting that CD39 expression is a phenotypic marker of CD8 + T cell exhaustion. Moreover, within the exhausted popu- 
(B) Quantification of cells in (A) that produce both TNFα and IFN-γ relative to IFN-γ only. (C, D) Cytokine production by P14 cells (C) gated from an infection as in (A) and summary of IFN-γ and TNFα producing cells. (E, F) Mean fluorescence intensity (MFI) of IFN-γ in IFN-γ positive endogenous (E) and transferred P14 cells (F).
Statistical significance was assessed with paired Student's t-test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. [14, 35] . Additional studies will therefore be required to determine the extent to which T cell activation (rather than exhaustion per se) contributes to the up-regulation of CD39 and PD-1 in chronic infection. However, the strong association between CD39 expression and the hallmark phenotypic features of T cell exhaustion in humans and a mouse model suggests that it can serve as a valuable marker of the exhausted T cells state. The expression of molecules, such as PD-1, that inhibit T cell function has been used to identify exhausted CD8 + T cells in several studies of human chronic infection and cancer [2] .
However, there are important distinctions between the pattern of CD39 expression and that of inhibitory receptors. Many inhibitory receptors, such as PD-1 [3, 8, 36] and CD244 [37, 38] are also expressed by a substantial fraction of CD8 + T cells in healthy donors that are not exhausted. In contrast, CD39 expression is found in only a very small minority of CD8 + T cells from healthy donors. This expression pattern suggests that CD39 expression, particularly in combination with PD-1, may be useful as a more specific phenotype of exhausted CD8 + T cells, at least in HCV and HIV infection. In addition, CD39 may provide a useful marker to isolate exhausted CD8 + T cells in settings such as tumor-specific responses where very few reagents are available to identify antigen-specific T cells. Importantly, while CD39 is rare in the CD8 + compartment in healthy donors, it is expressed by CD4 + Tregs-as is PD-1 -making it difficult to distinguish between exhausted CD4 + T cells and Tregs by CD39 expression alone.
Analysis of global expression profiles of CD39 + versus CD39 -CD8 + T cells in HCV-infected subjects showed that the CD39 + fraction was strongly enriched for genes related to proliferation. This may at first seem counterintuitive, given the functional defects that have been described in exhausted CD8 + T cells [2, 5] . However, data from the mouse model of chronic infection suggest that, unlike memory CD8 + T cells, exhausted CD8 + T cells are dependent on continuous exposure to viral antigen to ensure their survival and undergo extensive cell division at a rate higher than that seen in physiological homeostatic proliferation of the memory CD8 + T cell pool [39] . Exhausted CD8 + T cells therefore have a paradoxical increase in their proliferation in vivo despite reduced proliferative potential in vitro [40] , explaining the increased expression of proliferation-associated genes in CD39 + CD8 + T cells in HCV infection and in mouse exhausted CD8 + T cells [9, 41] .
Recent studies of exhausted CD8 + T cells have revealed that two distinct states of virus-specific CD8 + T cells exist in chronically infected mice and humans [9, 10] . Differential expression of the T-box transcription factors T-bet and Eomes characterize two populations, which form a progenitor-progeny relationship. T-bet high cells display low intrinsic turnover but are capable veys of CD39 expression in human chronic infections will be required to determine whether this marker can be used as a surrogate for terminal exhaustion. However, the strong association between CD39 expression and the key features of terminal exhaustion suggests that it may prove a useful marker to help distinguish between "reversible" and "irreversible" T cell exhaustion. Moroever, the fact that isolating CD39 + cells does not require intracellular staining (as is required for T-bet and Eomes) makes this marker useful for studying the function of this terminally exhausted cells ex vivo.
The fact that CD39 is expressed by a slightly larger fraction of HCV-specific CD8 + T cells than HIV-specific CD8 + T cells may be related to differences in the timing of blood sampling during the course of infection, or may be due to differences in the extent of antigen-load and inflammation in the two infections. Alternatively, it may be consistent with a model in which HCV-specific CD8 + T cells are in a more "terminal" state of exhaustion than CD8 + T cells specific for HIV. This possibility is supported by profound loss of HCV-specific CD8 + T cells over the course of chronic infection [42] that is not seen in the HIV-specific CD8 + T cell pool, consistent with the clonal deletion seen in mouse models of extreme CD8 + T cell exhaustion [43, 44] It is tempting to speculate that expression of CD39 contributes to the dysfunction of exhausted T cells [45] . For instance, the expression of CD39 might enable CD8 + T cells to provide negative regulation in an autocrine or juxtacrine fashion via adenosine [18] [19] [20] in the same manner as Tregs [15, 35] . The fact that CD39 requires both a substrate (ATP) and a downstream enzyme (CD73) to generate adenosine could provide a mechanism to ensure that this negative signaling occurred only in certain contexts such as in inflamed, damaged tissues where the extracellular concentrations of ATP are high and CD73-expressing cells are present [46] . Moreover, CD39-expressing CD8 + T cells may contribute to the general inhibitory milieu by contributing to the inhibition of activated T cells that express the adenosine receptor but are not yet exhausted. It will therefore be important to determine whether inhibition of CD39 activity could provide an additional therapeutic strategy to rescue the function of exhausted T cells.
Materials and Methods
Human Subjects
Healthy human donors were recruited at the Kraft family Blood Donor Center, Dana-Farber Cancer Institute. All human subjects with HCV infection were recruited at the Gastrointestinal Unit and the Department of Surgery of the Massachusetts General Hospital (Boston, MA) (S1 Table) .
Individuals with chronic HCV infection (n = 82) were defined by positive anti-HCV antibody and detectable viral load. Patients with spontaneous clearance of HCV, termed resolvers (n = 30), were defined by positive anti-HCV antibody but an undetectable viral load for at least 6 months. The estimated time of infection was calculated either using the exposure date or the time of onset of symptoms and peak ALT (which are assumed to be 7 weeks post infection). All HCV patients were treatment naive and studied at 5.9 and 219.7 weeks post infection. HCV RNA levels were determined using the VERSANT HCV RNA 3.0 (bDNA 3.0) assay (Bayer Diagnostics).
All HIV infected subjects (n = 40) were recruited at the Ragon Institute at the Massachusetts General Hospital (Boston, USA) or the Peter Medawar Building for Pathogen Research (Oxford, UK) (S2 Table) . HIV controllers included elite controllers (n = 5) defined as having HIV RNA below the level of detection (<75 viral copies per ml) and viremic controllers (n = 7) with HIV RNA levels < 2,000 viral copies per ml. HIV chronic progressors (n = 28) were defined as having > 2,000 viral copies per ml. All subjects were off therapy. Viral load during chronic infection was measured using the Roche Amplicor version 1.5 assay.
MHC Class I Tetramers
Major histocompatibility complex (MHC) class I HIV Gag-specific tetramers were produced as previously described [47] or obtained from Proimmune. CMV-and EBV-specific MHC class I dextramers conjugated with FITC and APC were purchased from Immudex. Mouse MHC class I tetramers of H-2D b complexed with LCMV GP 276-286 were produced as previously described [48, 49] . Biotinylated complexes were tetramerized using allophycocyanin-conjugated streptavidin (Molecular Probes). The complete list of multimers can be found in supplemental materials (S3 Table) .
Antibodies and flow cytometry
The following anti-human (hu) and anti-mouse (m) fluorochrome-conjugated antibodies were used for flow cytometry: huCD8α (RPA-T8), huCD4 (OKT4), huCD3 (OKT3), huCD39 (A1), huPD-1 (EG12.2H7), huCD25 (BC96), huCCR7 (G043H7), huCD45RA (HI100), huT-bet (4B10), mCD8α (53-6.7), mCD4 (GK1. 
Mice and infections
Wild-type C57BL/6J mice were purchased from The Jackson Laboratory. Female mice (6-8 weeks old) were infected with 2 x 10 5 plaque forming units (p.f.u.) of LCMV-Armstrong intraperitoneally or 4 x 10 6 p.f.u. of LCMV-Clone 13 intravenously and analyzed at indicated time points by homogenizing the spleen into a single-cell suspension, Ammonium-Chloride-Potassium lysis of red blood cells, followed by antibody staining. For experiments involving P14 cell transfers, Ly5.1+ P14s were isolated from peripheral blood, and 500 P14 cells were transferred i.v. into 5-6 week old wild-type female mice one day prior to infection. Viruses were propagated as described previously [48] [49] [50] .
HPLC analysis of ATP levels
The concentration of ATP hydrolyzed by CD8 + T cells from subjects with HCV infection (n = 6) was assessed by high performance liquid chromatography (HPLC) as previously described [51] . Briefly, 10,000 CD39 + CD8 + T cells were sorted and placed on ice to minimize ATP production by cells. 20 μM of ATP was added and incubated for 1 h at 37°C in 5% CO 2 to allow for cellular activity to increase and CD39-mediated ATP hydrolysis to occur. Samples were then placed in an ice bath for 10 min to halt enzymatic activity, collected, and centrifuged for 10 min at 380 x g and 0°C. Cells were discarded and supernatant centrifuged again to remove remaining cells (2350 x g, 5 min, 0°C). The resulting RPMI samples (160 μl) were treated with 10 μl of an 8 M perchloric acid solution (Sigma-Aldrich) and centrifuged at 15,900 x g for 10 min at 0°C to precipitate proteins. In order to neutralize the pH of the resulting solutions and to remove lipids, supernatants (80 μl) were treated with 4 M K 2 HPO 4 (8 μl) and tri-N-octylamine (50 μl). These samples were mixed with 50 μl of 1,1,2-trichloro-trifluoroethane and centrifuged (15,900 x g, 10 min, 0°C) and this last lipid extraction step was repeated once. The resulting supernatants were subjected to the following procedure to generate fluorescent etheno-adenine products: 150 μl supernatant (or nucleotide standard solution) was incubated at 72°C for 30 min with 250 mM Na 2 HPO 4 (20 μl) and 1 M chloroacetaldehyde (30 μl; Sigma-Aldrich) in a final reaction volume of 200 μl, resulting in the formation of 1, N6-etheno derivatives as previously described [51] . Samples were placed on ice, alkalinized with 0.5 M NH 4 HCO 3 (50 μl), filtered with a 1 ml syringe and 0.45 μM filter and analyzed using a Waters HPLC system and Supelcosil 3 μM LC-18T reverse phase column (Sigma), consisting of a gradient system described previously, a Waters autosampler, and a Waters 474 fluorescence detector [52] . Empower2 software was used for the analysis of data and all samples were compared with water and ATP standard controls as well as a sample with no cells to determine background degradation of ATP.
Microarray data acquisition CD8 + T cells from subjects with HCV infection were sorted and pelleted and re-suspended in TRIzol (Invitrogen). RNA extraction was performed using the RNAdvance Tissue Isolation kit (Agencourt). Concentrations of total RNA were determined with a Nanodrop spectrophotometer or Ribogreen RNA quantification kits (Molecular Probes/Invitrogen). RNA purity was determined by Bioanalyzer 2100 traces (Agilent Technologies). Total RNA was amplified with the WT-Ovation Pico RNA Amplification system (NuGEN) according to the manufacturer's instructions. After fragmentation and biotinylation, cDNA was hybridized to HG-U133A 2.0 microarrays (Affymetrix). Data have been deposited in Gene Expression Omnibus with accession code GSE72752.
Statistics
Prior to analysis, microarray data were pre-processed and normalized using robust multichip averaging, as previously described [53] . Differentially gene expression and consensus clustering [54] were performed using Gene-E software (www.broadinstitute.org/cancer/software/ GENE-E/), and gene set enrichment analysis was performed as described previously using gene sets from MSigDB [55] or published resources [29, 32] .
Consensus hierarchical clustering was performed using the top 10% of genes that varied across the dataset, without reference to sample identity. Consensus cluster assesses the "stability" of the clusters discovered using unbiased methods such as hierarchical clustering i.e. the robustness of the putative clusters to sampling variability. The basic assumption is that if the data represent a sample of items drawn from distinct sub-populations, a different sample drawn from the same sub-populations, would result in cluster composition and number should not be radically different. Therefore, the more the attained clusters are robust to sampling variability, the greater the likelihood that the observed clusters represent real structure. The result of consensus clustering is a matrix that shows, for each pair of samples, the proportion of clustering runs on sub-sampled data in which those two items cluster together (shown on a scale of 0 to 1).
Enrichment Map analysis of GSEA results was performed as described [56] . The gene signature of exhaustion was generated by identifying the top 200 genes upregulated in CD8 + T cells responding to chronic vs. acute LCMV infection in microarray data from a previously published study [29] .
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